GlobeNewswire

MannKind to Participate in Upcoming Investor Conferences
10/11/2026
DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) , today announced that Chief Executive Officer, Michael Castagna, and Chief Financial Officer, Chris [...]
Shane Schaffer, Cingulate Chairman and CEO, Provides Update on CTx-1301 in Interview with Innovators with Jane King
10/11/2026
KANSAS CITY, Kan., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform to develop next-generation [...]
Vor Bio To Participate in 2026 Jefferies Global Healthcare Conference
10/11/2026
BOSTON, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that management will participate in a fireside [...]
TaiMed Biologics Announces Publication in The Lancet HIV of Phase 1b/2a Study of Long-Acting Dual-Antibody HIV Maintenance Regimen TMB-365/TMB-380
10/11/2026
Further analysis of previously announced Phase 2a results showed 94% of evaluable participants maintained viral suppression through 24 weeks, with no confirmed virologic failures Study evaluated TMB-365/TMB-380 without [...]
Corbus Pharmaceuticals Reports Q3 2026 Financial Results and Provides a Corporate Update
10/11/2026
Dosed first patient in TEMPO-1 registrational study of sutantatug envedotin (CRB-701) in patients with 2L+ oropharyngeal cancer Reported topline data from the CANYON-1 Phase 1b obesity study of CRB-913 demonstrating [...]
Paragon Genomics and Intelliseq Partner to Accelerate High-Throughput Pharmacogenomic Profiling
10/11/2026
Learn more about the unique PGx capabilities enabled by the collaboration in an Innovation Spotlight presentation at AMP 2026 on November 13, 2026 FREMONT, Calif. and MURRIETA, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- [...]
AchieveRx Reports Third Quarter 2026 Financial Results and Provides Business Updates
10/11/2026
Launched new corporate brand as AchieveRx, The Quit Company (Nasdaq: QUIT) Presented 52-week ORCA-OL data at the CHEST 2026 Annual Meeting showing that nearly one in three adults still smoking or vaping after a [...]
Krystal Biotech to Present at Upcoming Investor Conferences
10/11/2026
PITTSBURGH, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that management will take part in fireside chats and host investor meetings at the following conferences [...]
Valneva Reports Sustained 94% Seroresponse Five Years After a Single Dose of Chikungunya Vaccine IXCHIQ®
10/11/2026
94% of participants maintained seroresponse five years after a single vaccination Comparable antibody persistence observed in older (65+) and younger adults Data further reinforce IXCHIQ ® 's differentiated profile with [...]
Valneva annonce un taux de séroréponse de 94% cinq ans après une dose unique du vaccin contre le chikungunya IXCHIQ®
10/11/2026
94% des participants ont maintenu une séroréponse cinq ans après une dose unique du vaccin La persistance des anticorps chez les adultes âgés de 65 ans et plus est comparable à celle des jeunes adultes Ces données [...]
MaxCyte Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Total Revenue Guidance
10/11/2026
MaxCyte will host its third quarter 2026 earnings call today, November 10th, at 8:30 a.m. Eastern Time Third Quarter and Recent Business Highlights: Reports total revenue of $10.2 million for the third quarter of 2026, [...]
Marvel Announces Final Shank3 Data: MB-204 Highly Effective at Reversing Autism Behaviours
10/11/2026
CALGARY, Alberta, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Marvel Biosciences Corp. (TSXV: MRVL | OTCQB: MBCOF) , and its wholly-owned subsidiary, Marvel Biotechnology Inc. (collectively the “Company” or “Marvel”), a drug [...]
Researchers Discover Blood-Based Warning Signal for Ovarian Cancer at its Earliest, Precancerous Stage
10/11/2026
This first-of-its-kind breakthrough opens the possibility of detection years earlier compared to current methods NEWPORT BEACH, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Hoag researchers announced a first in the world [...]
Codexis Enters into $60 Million Term Loan Facility with Trinity Capital
10/11/2026
Initial drawdown of $42.5 million to refinance existing term loan REDWOOD CITY, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (Nasdaq: CDXS), a leading provider of enzymatic solutions for efficient and [...]
Immuron Engages LifeSci Capital as its Exclusive Financial Advisor to Explore Strategic Initiatives
10/11/2026
MELBOURNE, Australia, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) today announced that it has engaged LifeSci Capital to serve as its exclusive financial advisor to assist in evaluation of [...]
MaxCyte to Acquire Akron Bio, Expanding its Offerings Across Cell Therapy Manufacturing and Expecting to Nearly Double Revenue Base
10/11/2026
Akron Bio is a leading supplier of GMP-grade reagents and ancillary materials Expands MaxCyte’s footprint across the cell therapy manufacturing workflow and establishes a combined portfolio supporting five commercially [...]
Dimora Medical Supports Empower HS 2026, Advancing Everyday Wound Care for the HS Community
10/11/2026
Silicone foam dressings featuring MegaSorb™ technology were included in attendee gift bags to support at-home management of exuding wounds New York, USA, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Dimora Medical, a pioneer in [...]
Australian ALS therapy aimed at halting disease progression and restoring function advances to Phase 2 trial
10/11/2026
Video interviews, overlay and photos here BRISBANE, Australia, Nov. 10, 2026 (GLOBE NEWSWIRE) -- An Australian-developed therapy aimed at halting the progression of amyotrophic lateral sclerosis (ALS) and restoring [...]
UsAgainstAlzheimer’s Names Danielle Carnival, Ph.D., Chief Executive Officer; Co-Founder George Vradenburg Continues as Executive Chairman
10/11/2026
Appointment builds on momentum and urgency in the fight to end Alzheimer’s WASHINGTON, Nov. 10, 2026 (GLOBE NEWSWIRE) -- UsAgainstAlzheimer’s (UsA2) today announced the appointment of Danielle Carnival, Ph.D., as Chief [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum